Cochlear Limited shares rocket as it posts BIG profit growth

Cochlear Limited (ASX:COH) announced a profit of $94 million, up 32%, on sales revenue of $558 million, up 32%.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Cochlear Limited (ASX: COH), the world's leading implantable hearing device manufacturer, today announced its results to the market.

In the six-month period ended 31 December 2015, Cochlear achieved revenue growth of 27%, to $558 million, with a net profit of $94 million up 32% over the prior corresponding period.

The results were buoyed by currency movements, however, even in constant currency, the company achieved sales growth of 16%. Product releases and investments in growth initiatives helped drive market growth.

"The positive momentum we saw in FY15 has continued into HY16 with both our Implant Business and Services business delivering strong growth," Cochlear CEO, Chris Smith, said. "The business is benefitting from the rollout of new products launched in FY15 and the continued growth investment in strategic growth initiatives that commenced two years ago."

Each of the company's key geographies fired on all cylinders during the half, with the Asia Pacific segment more than doubling operating profit year over year.

"We are particularly pleased with the Implant business, which delivered sales growth across both developed and emerging markets, with some countries like the United States (US) experiencing accelerated market growth," Mr Smith said.

The Implant's business achieved sales growth of 62%, while Services which includes sound processor upgrades and accessories, achieved growth of 25%. Bone conduction & acoustic implants revenue jumped 13%.

Pleasingly, the company's board announced an interim dividend of 110 cents per share, up 22% over last year's payout, with 100% franking. The company will continue ahead with a targeted payout ratio of 70% of profits.

For the remainder of FY16, Cochlear upgraded its financial outlook to a net profit of between $180 million and $190 million, thanks in large part to currency tailwinds. Based on this guidance, net profit would be between 23% and 30% higher than last year, the company said.

"The hearing loss market offers an incredible business opportunity with over 360 million people worldwide experiencing disabling hearing loss, with nearly one in three people over the age of 65 affected by hearing loss," Mr Smith added. "With global market penetration for implantable hearing solutions less than 5%, there remains a significant, unmet and addressable clinical need that will continue to underpin the long-term sustainable growth of our business."

Foolish takeaway

Cochlear shares trade at a premium valuation to the market. However, that premium is arguably justified by the continued growth the business serves up. While some dyed-in-the-wool value investors may be turned off by the valuation, I think that if you're investing for five years or more, Cochlear is a buy.

Motley Fool writer/analyst Owen Raszkiewicz owns shares of Cochlear. Owen welcomes -- and encourages -- your feedback on Google+, LinkedIn or you can follow him on Twitter @ASXinvest. Unless otherwise noted, the author does not have a position in any stocks mentioned by the author in the comments below. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »